Skip to main content
NCBI home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1982 Apr;35(4):395–400. doi: 10.1136/jcp.35.4.395

Incidence of hypercalcaemia and primary hyperparathyroidism in relation to the biochemical profile.

J S Harrop, J E Bailey, J S Woodhead
PMCID: PMC497668  PMID: 7076867

Abstract

Over a period of one year, 24500 patients underwent a biochemical profile investigation. Seven hundred and thirty-eight (3%) patients had a plasma calcium concentration of greater than 2.60 mmol/l, and hypercalcaemia was confirmed in 49.8% of those subjects from whom a second fasting sample was received. Primary hyperparathyroidism and malignant disease were the two commonest causes of hypercalcaemia, occurring with equal frequency. The overall incidence of primary hyperparathyroidism in our population was 1:680. Over 75% of the patients with primary hyperparathyroidism appeared to have asymptomatic disease. The merits of including a plasma calcium determination in a biochemical profile would seem to depend particularly on the natural history of asymptomatic primary hyperparathyroidism.

Full text

PDF
395

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Addison G. M., Hales C. N., Woodhead J. S., O'Riordan J. L. Immunoradiometric assay of parathyroid hormone. J Endocrinol. 1971 Mar;49(3):521–530. doi: 10.1677/joe.0.0490521. [DOI] [PubMed] [Google Scholar]
  2. Barrett A. E., Cameron S. J., Fraser C. G., Penberthy L. A., Shand K. L. A clinical view of analytical goals in clinical biochemistry. J Clin Pathol. 1979 Sep;32(9):893–896. doi: 10.1136/jcp.32.9.893. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Boonstra C. E., Jackson C. E. Serum calcium survey for hyperparathyroidism: results in 50,000 clinic patients. Am J Clin Pathol. 1971 May;55(5):523–526. doi: 10.1093/ajcp/55.5.523. [DOI] [PubMed] [Google Scholar]
  4. Christensson T., Hellström K., Wengle B., Alveryd A., Wikland B. Prevalence of hypercalcaemia in a health screening in Stockholm. Acta Med Scand. 1976;200(1-2):131–137. doi: 10.1111/j.0954-6820.1976.tb08208.x. [DOI] [PubMed] [Google Scholar]
  5. Coe F. L., Favus M. J. Does mild, asymptomatic hyperparathyroidism require surgery? N Engl J Med. 1980 Jan 24;302(4):224–225. doi: 10.1056/NEJM198001243020408. [DOI] [PubMed] [Google Scholar]
  6. Conceicao S. C., Weightman D., Smith P. A., Luno J., Ward M. K., Kerr D. N. Serum ionised calcium concentration: measurement versus calculation. Br Med J. 1978 Apr 29;1(6120):1103–1105. doi: 10.1136/bmj.1.6120.1103. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Drezner M. K., Lebovitz H. E. Primary hyperparathyroidism in paraneoplastic hypercalcaemia. Lancet. 1978 May 13;1(8072):1004–1006. doi: 10.1016/s0140-6736(78)90734-1. [DOI] [PubMed] [Google Scholar]
  8. Flynn F. V., Piper K. A., Garcia-Webb P., McPherson K., Healy M. J. Biological and analytical variation of commonly determined blood constituents in healthy blood donors. Clin Chim Acta. 1976 Jul 1;70(1):179–189. doi: 10.1016/0009-8981(76)90021-8. [DOI] [PubMed] [Google Scholar]
  9. Haff R. C., Black W. C., Ballinger W. F. Primary hyperparathyroidism: changing clinical, surgical and pathologic aspects. Ann Surg. 1970 Jan;171(1):85–92. doi: 10.1097/00000658-197001000-00013. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Haff R. C., Black W. C., Ballinger W. F. Primary hyperparathyroidism: changing clinical, surgical and pathologic aspects. Ann Surg. 1970 Jan;171(1):85–92. doi: 10.1097/00000658-197001000-00013. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Heath H., 3rd, Hodgson S. F., Kennedy M. A. Primary hyperparathyroidism. Incidence, morbidity, and potential economic impact in a community. N Engl J Med. 1980 Jan 24;302(4):189–193. doi: 10.1056/NEJM198001243020402. [DOI] [PubMed] [Google Scholar]
  12. Heedman P. A., Stenström G. Clinical findings in patients with hypercalcaemia. A preliminary investigation based on biochemical screening. Acta Med Scand. 1973 Mar;193(3):167–173. [PubMed] [Google Scholar]
  13. Holland W. W. Taking stock. Lancet. 1974 Dec 21;2(7895):1494–1497. doi: 10.1016/s0140-6736(74)90230-x. [DOI] [PubMed] [Google Scholar]
  14. Keating F. R., Jr, Jones J. D., Elveback L. R. Distribution of serum calcium and phosphorus values in unselected ambulatory patients. J Lab Clin Med. 1969 Sep;74(3):507–514. [PubMed] [Google Scholar]
  15. Ladenson J. H., Lewis J. W., Boyd J. C. Failure of total calcium corrected for protein, albumin, and pH to correctly assess free calcium status. J Clin Endocrinol Metab. 1978 Jun;46(6):986–993. doi: 10.1210/jcem-46-6-986. [DOI] [PubMed] [Google Scholar]
  16. Larsson L., Ohman S. Serum ionized calcium and corrected total calcium in borderline hyperparathyroidism. Clin Chem. 1978 Nov;24(11):1962–1965. [PubMed] [Google Scholar]
  17. Mays E. T., Weakley S. D. Serum multichannel autoanalyzers in the detection of hypercalcemia and hyperparathyroidism. Surg Gynecol Obstet. 1971 Oct;133(4):603–608. [PubMed] [Google Scholar]
  18. McLellan G., Baird C. W., Melick R. Hypercalcaemia in an Australian hospital adult population. Med J Aust. 1968 Aug 24;2(8):354–356. doi: 10.5694/j.1326-5377.1968.tb82823.x. [DOI] [PubMed] [Google Scholar]
  19. Muldowney F. P., Freaney R., McMullin J. P., Towers R. P., Spillane A., O'Connor P., O'Donohoe P., Moloney M. Serum ionized calcium and parathyroid hormone in renal stone disease. Q J Med. 1976 Jan;45(177):75–86. [PubMed] [Google Scholar]
  20. Mundy G. R., Cove D. H., Fisken R. Primary hyperparathyroidism: changes in the pattern of clinical presentation. Lancet. 1980 Jun 21;1(8182):1317–1320. doi: 10.1016/s0140-6736(80)91783-3. [DOI] [PubMed] [Google Scholar]
  21. Pain R. W., Rowland K. M., Phillips P. J., Duncan B. M. Current "corrected" calcium concept challenged. Br Med J. 1975 Dec 13;4(5997):617–619. doi: 10.1136/bmj.4.5997.617. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Payne R. B., Little A. J., Williams R. B., Milner J. R. Interpretation of serum calcium in patients with abnormal serum proteins. Br Med J. 1973 Dec 15;4(5893):643–646. doi: 10.1136/bmj.4.5893.643. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Purnell D. C., Scholz D. A., Smith L. H., Sizemore G. W., Black M. B., Goldsmith R. S., Arnaud C. D. Treatment of primary hyperparathyroidism. Am J Med. 1974 Jun;56(6):800–809. doi: 10.1016/0002-9343(74)90808-0. [DOI] [PubMed] [Google Scholar]
  24. Stenström G., Heedman P. A. Clinical findings in patients with hypercalcaemia. A final investigation based on biochemical screening. Acta Med Scand. 1974 Jun;195(6):473–477. doi: 10.1111/j.0954-6820.1974.tb08174.x. [DOI] [PubMed] [Google Scholar]
  25. Walton R. J., Bijvoet O. L. Nomogram for derivation of renal threshold phosphate concentration. Lancet. 1975 Aug 16;2(7929):309–310. doi: 10.1016/s0140-6736(75)92736-1. [DOI] [PubMed] [Google Scholar]
  26. Whitehead T. P., Wootton I. D. Biochemical profiles for hospital patients. Lancet. 1974 Dec 14;2(7894):1439–1443. doi: 10.1016/s0140-6736(74)90088-9. [DOI] [PubMed] [Google Scholar]
  27. Wilson J. M. Current trends and problems in health screening. J Clin Pathol. 1973 Aug;26(8):555–563. doi: 10.1136/jcp.26.8.555. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES